Physician profile
Bryan Procopio
NPI 1205415627
$3,214.70
in general payments reported to CMS, 2019-2025
22 companies · $814 in 2025
The $814 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.47 · 2022: $379 · 2023: $940 · 2024: $1,034 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,498 · Travel and Lodging: $175 · Entertainment: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,497.75 |
| Travel and Lodging | $174.65 |
| Entertainment | $116.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $465.16 | 2022-2025 | Cequa |
| Bausch & Lomb Americas INC. | $344.07 | 2022-2025 | Infuse, Miebo, Xiidra |
| Dompe US, INC. | $268.75 | 2023-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $264.87 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $258.13 | 2023-2025 | Dailies Total1, Total30, Precision 1 |
| Oyster Point Pharma, INC. | $204.55 | 2022-2025 | Tyrvaya, Ryzumvi |
| Oculus, INC. | $174.65 | 2024 | Na |
| Sight Sciences, INC. | $166.96 | 2022 | |
| Biotissue Holdings INC. | $157.00 | 2023-2025 | |
| Coopervision INC. | $153.03 | 2023-2025 | Myday Contact Lens, Clariti Contact Lens, Paragon Crt |
| Abb Con-Cise Optical Group LLC | $130.01 | 2024 | Spectacle Lenses, Contact Lens |
| Lkc Technologies, INC. | $117.34 | 2023 | |
| Optos, INC. | $116.55 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $80.76 | 2022-2023 | |
| Harrow Eye, LLC | $76.72 | 2025 | Vevye |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $72.51 | 2023-2024 | |
| Rxsight INC | $66.91 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.64 | 2021 | |
| Eyevance Pharmaceuticals LLC | $20.21 | 2022 | |
| Allergan, INC. | $15.33 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $14.72 | 2024 | |
| Kala Pharmaceuticals, INC. | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Procopio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.